Skip to main content
. 2018 May 23;9(6):1054–1058. doi: 10.1039/c8md00057c

Table 2. The VEGFR-2 inhibitory activity of the target compounds.

Entry VEGFR-2 IC50 a (μM)
8a 0.87 ± 0.06
8j 0.53 ± 0.09
8l 0.29 ± 0.02
8u 1.22 ± 0.12
Sorafenib 0.95 ± 0.09

aIC50 values are the mean ± S.D. of three separate experiments.